Drug Type ASO |
Synonyms- |
Target |
Action blockers |
Mechanism CACNA1G blockers(calcium voltage-gated channel subunit alpha1 G blockers) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Pain | Preclinical | South Korea | 16 Apr 2025 | |
Epilepsy, Absence | Preclinical | South Korea | 16 Apr 2025 | |
Epilepsy, Frontal Lobe | Preclinical | South Korea | 16 Apr 2025 | |
Essential Tremor | Preclinical | South Korea | 16 Apr 2025 | |
Parkinson Disease | Preclinical | South Korea | 16 Apr 2025 |